⌘K

Login Start Free

Clovis Oncology, Inc.·4

Jan 3, 4:45 PM ET

SPICKSCHEN THORLEF 4

4 · Clovis Oncology, Inc. · Filed Jan 3, 2019

Insider Transaction Report

Form 4

Period: 2019-01-03

Clovis Oncology, Inc.CLVS

SPICKSCHEN THORLEF

Director

Transactions

Exercise/Conversion
Common Stock
2019-01-03$3.08/sh+6,896$21,240→ 14,514 total
Exercise/Conversion
Common Stock
2019-01-03$0.29/sh+25,862$7,500→ 40,376 total
Exercise/Conversion
Stock Option (right to buy)
2019-01-03−25,862→ 0 total
Exercise: $0.29Exp: 2019-08-26→ Common Stock (25,862 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-01-03−6,896→ 0 total
Exercise: $3.08Exp: 2020-12-02→ Common Stock (6,896 underlying)

Footnotes (1)

[F1]The option was exercisable as of the reporting person's previous filing on Form 3, dated as of November 15, 2011.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION